{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:44:17Z","timestamp":1768689857112,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11934-019-0940-2","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T07:02:57Z","timestamp":1573282977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management Strategies for Nocturia"],"prefix":"10.1007","volume":"20","author":[{"given":"Danielle J.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curran J.","family":"Emeruwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"940_CR1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.juro.2010.04.011","volume":"184","author":"JR Bosch","year":"2010","unstructured":"Bosch JR, Weiss JP. The prevalence and causes of nocturia. J Urol. 2010;184:440\u20136.","journal-title":"J Urol"},{"key":"940_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.juro.2010.09.108","volume":"185","author":"V Kupelian","year":"2011","unstructured":"Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the third National Health and Nutrition examination survey. J Urol. 2011;185:571\u20137.","journal-title":"J Urol"},{"key":"940_CR3","unstructured":"Weiss JP, Marshall SD: Nocturia. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh Urology, Eleventh Edition. Elsevier (2016)."},{"key":"940_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/sleep\/31.5.635","volume":"31","author":"MH Hall","year":"2008","unstructured":"Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008;31:635\u201343.","journal-title":"Sleep"},{"key":"940_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4614-1156-7_3","volume-title":"Nocturia: causes, consequences, and clinical approaches","author":"S Ancoli-Israel","year":"2012","unstructured":"Ancoli-Israel S, Bliwise D, Noorgaard JP. Nocturia and sleep disorders. In: Weiss JP, Blaivas JG, Van Kerrebroeck PEV, et al., editors. Nocturia: causes, consequences, and clinical approaches. New York: Springer-Verlag; 2012. p. 37."},{"key":"940_CR6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1532-5415.2004.52264.x","volume":"52","author":"YW Endeshaw","year":"2004","unstructured":"Endeshaw YW, Johnson TM, Kutner MH, Ouslander JG, Bliwise DL. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc. 2004;52:957\u201360.","journal-title":"J Am Geriatr Soc"},{"key":"940_CR7","doi-asserted-by":"publisher","unstructured":"Holm-Larsen T, Weiss JP, Langkilde LK. Economic burden of nocturia in the us adult population. J Urol. 2010. \nhttps:\/\/doi.org\/10.1016\/j.juro.2010.02.045\n\n.","DOI":"10.1016\/j.juro.2010.02.045"},{"issue":"6","key":"940_CR8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0306-3623(94)00310-J","volume":"26","author":"Ragnar Asplund","year":"1995","unstructured":"Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol Vasc Syst. 1995;26:1203\u20139.","journal-title":"General Pharmacology: The Vascular System"},{"key":"940_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167\u201378.","journal-title":"Neurourol Urodyn"},{"key":"940_CR10","doi-asserted-by":"publisher","unstructured":"Weiss JP. Nocturia: \"do the math\". J Urol. 2006. \nhttps:\/\/doi.org\/10.1016\/S0022-5347(05)00312-5\n\n.","DOI":"10.1016\/S0022-5347(05)00312-5"},{"key":"940_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000446-200701000-00022","volume":"107","author":"CN Rottmann","year":"2007","unstructured":"Rottmann CN. SSRIs and the syndrome of inappropriate antidiuretic hormone secretion. Am J Nurs. 2007;107:51\u20138 quiz 58\u20139.","journal-title":"Am J Nurs"},{"key":"940_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-410X.2005.05408.x","volume":"95","author":"R Asplund","year":"2005","unstructured":"Asplund R, Johansson S, Henriksson S, Isacsson G. Nocturia, depression and antidepressant medication. BJU Int. 2005;95:820\u20133.","journal-title":"BJU Int"},{"key":"940_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.38.117","volume":"38","author":"K Otsuka","year":"2002","unstructured":"Otsuka K, Tanaka H, Horinouchi T, Koike K, Shigenobu K, Tanaka Y. Functional contribution of voltage-dependent and Ca2-activated K (BKCa) channels to the relaxation of Guinea-pig aorta in response to natriuretic peptides. J Smooth Muscle Res. 2002;38:117\u201329.","journal-title":"J Smooth Muscle Res"},{"key":"940_CR14","doi-asserted-by":"publisher","first-page":"F359","DOI":"10.1152\/ajprenal.1978.235.4.f359","volume":"235","author":"J Guzzo","year":"1978","unstructured":"Guzzo J, Cox M, Kelley AB, Singer I. Tetracycline-induced inhibition of Na transport in the toad urinary bladder. Am J Physiol Ren Physiol. 1978;235:F359\u201366. \nhttps:\/\/doi.org\/10.1152\/ajprenal.1978.235.4.f359\n\n.","journal-title":"Am J Physiol Ren Physiol"},{"key":"940_CR15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1172\/JCI117863","volume":"95","author":"D Marples","year":"1995","unstructured":"Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Investig. 1995;95:1838\u201345.","journal-title":"J Clin Investig"},{"key":"940_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1464-410X.1998.00511.x","volume":"81","author":"C Reynard","year":"1998","unstructured":"Reynard C, Yang A. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 1998;81:215\u20138.","journal-title":"Br J Urol"},{"key":"940_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0022-3999(04)00021-2","volume":"56","author":"C Guilleminault","year":"2004","unstructured":"Guilleminault C, Lin C, Gon\u00e7alves M, Ramos E. A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res. 2004;56:511\u20135.","journal-title":"J Psychosom Res"},{"key":"940_CR18","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Victor RG, Li N, Blyler CA, et al. Nocturia as an unrecognized symptom of uncontrolled hypertension in Black men aged 35 to 49 years. J Am Heart Assoc. 2019. \nhttps:\/\/doi.org\/10.1161\/jaha.118.010794\n\n This study links uncontrolled hypertension as an independent determinant of clinically important nocturia in a large cross-sectional community-based study of non-hispanic black men aged 35\u201349 years. Among 1673 black men, those with hypertension were 56% more likely than men with normotension to have nocturia after adjustment for diabetes mellitus and sleep apnea (adjusted odds ratio, 1.56; 95% CI, 1.25\u20131.94 [P\u2009<\u20090.0001]).","DOI":"10.1161\/jaha.118.010794"},{"issue":"1","key":"940_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jash.2012.12.004","volume":"7","author":"Carlos A. Feldstein","year":"2013","unstructured":"Feldstein CA. Nocturia in arterial hypertension: a prevalent, underreported, and sometimes underestimated association. J AM Soc Hypertens. 2013;7:75\u201384.","journal-title":"Journal of the American Society of Hypertension"},{"key":"940_CR20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1464-410X.2002.02791.x","volume":"89","author":"A Mattiasson","year":"2002","unstructured":"Mattiasson A, Abrams P, Kerrebroeck PV, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int. 2002;89:855\u201362.","journal-title":"BJU Int"},{"key":"940_CR21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/S0002-9378(03)00593-3","volume":"189","author":"G Lose","year":"2003","unstructured":"Lose G, Lalos O, Freeman RM, Kerrebroeck PV. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol. 2003;189:1106\u201313.","journal-title":"Am J Obstet Gynecol"},{"key":"940_CR22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/nau.22243","volume":"31","author":"JP Weiss","year":"2012","unstructured":"Weiss JP, Zinner NR, Klein BM, N\u00f8rgaard JP. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31:441\u20137.","journal-title":"Neurourol Urodyn"},{"key":"940_CR23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.juro.2013.02.037","volume":"190","author":"PK Sand","year":"2013","unstructured":"Sand PK, Dmochowski RR, Reddy J, Meulen EAVD. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013;190:958\u201364.","journal-title":"J Urol"},{"key":"940_CR24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.juro.2012.11.067","volume":"189","author":"JP Weiss","year":"2013","unstructured":"Weiss JP, Jumadilova Z, Johnson TM, Fitzgerald MP, Carlsson M, Martire DL, et al. Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency. J Urol. 2013;189:1396\u2013401.","journal-title":"J Urol"},{"key":"940_CR25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11255-011-0054-3","volume":"44","author":"H Zong","year":"2011","unstructured":"\u2022\u2022 Zong H, Yang C, Peng X, Zhang Y. Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials. Int Urol Nephrol. 2011;44:377\u201384 A meta-analysis of five studies involving 619 participants revealed that desmopressin significantly decreases the frequency of nocturnal voids, nocturnal urine volume, and nocturnal diuresis, resulting in extended duration of the first sleep period and improved sleep quality. The adverse effects of desmopressin were similar to those in the placebo group.","journal-title":"Int Urol Nephrol"},{"key":"940_CR26","doi-asserted-by":"publisher","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","volume":"300","author":"KV Juul","year":"2011","unstructured":"Juul KV, Klein BM, Sandstr\u00f6m R, Erichsen L, N\u00f8rgaard JP. Gender difference in antidiuretic response to desmopressin. Am J Physiol Ren Physiol. 2011;300:F1116\u201322. \nhttps:\/\/doi.org\/10.1152\/ajprenal.00741.2010\n\n.","journal-title":"Am J Physiol Ren Physiol"},{"key":"940_CR27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1464-410X.2012.11547.x","volume":"111","author":"O Yamaguchi","year":"2012","unstructured":"Yamaguchi O, Nishizawa O, Juul KV, N\u00f8rgaard JP. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int. 2012;111:474\u201384.","journal-title":"BJU Int"},{"key":"940_CR28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1464-4096.2001.02434.x","volume":"88","author":"P Tomasi","year":"2002","unstructured":"Tomasi P, Siracusano S, Monni A, Mela G, Delitala G. Decreased nocturnal urinary antidiuretic hormone excretion in enuresis is increased by imipramine. BJU Int. 2002;88:932\u20137.","journal-title":"BJU Int"},{"key":"940_CR29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.CIR.60.5.1045","volume":"60","author":"EG Giardina","year":"1979","unstructured":"Giardina EG, Bigger JT, Glassman AH, Perel JM, Kantor SJ. The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation. 1979;60:1045\u201352.","journal-title":"Circulation"},{"key":"940_CR30","doi-asserted-by":"publisher","first-page":"14124J","DOI":"10.1520\/jfs14124j","volume":"42","author":"JR Swanson","year":"1997","unstructured":"Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci. 1997;42:14124J. \nhttps:\/\/doi.org\/10.1520\/jfs14124j\n\n.","journal-title":"J Forensic Sci"},{"key":"940_CR31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00192-006-0239-y","volume":"18","author":"L Brubaker","year":"2006","unstructured":"Brubaker L, Fitzgerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J. 2006;18:737\u201341.","journal-title":"Int Urogynecol J"},{"key":"940_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eursup.2004.12.001","volume":"4","author":"B Djavan","year":"2005","unstructured":"Djavan B, Milani S, Davies J, Bolodeoku J. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study. Eur Urol Suppl. 2005;4:61\u20138.","journal-title":"Eur Urol Suppl"},{"key":"940_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/nau.23832","volume":"38","author":"MR Epstein","year":"2018","unstructured":"Epstein MR, Monaghan T, Weiss JP. Etiology of nocturia response in men with diminished bladder capacity. Neurourol Urodyn. 2018;38:215\u201322.","journal-title":"Neurourol Urodyn"},{"key":"940_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.1992.tb15448.x","volume":"69","author":"JA Cumming","year":"1992","unstructured":"Cumming JA, Chisholm GD. Changes in detrusor innervation with relief of outflow tract obstruction. Br J Urol. 1992;69:7\u201311.","journal-title":"Br J Urol"},{"key":"940_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.urology.2007.05.001","volume":"70","author":"D Margel","year":"2007","unstructured":"Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology. 2007;70:493\u20137.","journal-title":"Urology"},{"issue":"3","key":"940_CR36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11918-007-0018-3","volume":"5","author":"Fadi Housami","year":"2007","unstructured":"Housami F, Abrams P. Persistent detrusor overactivity after transurethral resection of the prostate. Curr Prostate Rep. 2007;5:126\u201332.","journal-title":"Current Prostate Reports"},{"key":"940_CR37","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0090-4295(02)02444-5","volume":"61","author":"K Yoshimura","year":"2003","unstructured":"Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, et al. Nocturia and benign prostatic hyperplasia. Urology. 2003;61:786\u201390.","journal-title":"Urology"},{"key":"940_CR38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-410X.2009.08969.x","volume":"105","author":"MM Van Dijk","year":"2010","unstructured":"Van Dijk MM, Wijkstra H, Debruyne FM, De La Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2010;105:1141\u20136.","journal-title":"BJU Int"},{"key":"940_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1442-2042.2010.02704.x","volume":"18","author":"V Simaioforidis","year":"2011","unstructured":"Simaioforidis V, Papatsoris AG, Chrisofos M, Chrisafis M, Koritsiadis S, Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol. 2011;18:243\u20138.","journal-title":"Int J Urol"},{"key":"940_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000069827.09120.79","volume":"170","author":"TM Johnson","year":"2003","unstructured":"Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative study trial. J Urol. 2003;170:145\u20138.","journal-title":"J Urol"},{"key":"940_CR41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.eururo.2012.07.004","volume":"62","author":"J-N Cornu","year":"2012","unstructured":"Cornu J-N, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, et al. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management\u2014a systematic review and meta-analysis. Eur Urol. 2012;62:877\u201390.","journal-title":"Eur Urol"},{"key":"940_CR42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.urology.2005.10.061","volume":"67","author":"R Rackley","year":"2006","unstructured":"Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006;67:731\u20136.","journal-title":"Urology"},{"key":"940_CR43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","volume":"190","author":"JP Weiss","year":"2013","unstructured":"Weiss JP, Herschorn S, Albei CD, Meulen EAVD. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013;190:965\u201372.","journal-title":"J Urol"},{"key":"940_CR44","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.juro.2007.07.013","volume":"178","author":"TM Johnson","year":"2007","unstructured":"Johnson TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;178:2045\u201351.","journal-title":"J Urol"},{"key":"940_CR45","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","volume":"296","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. Jama. 2006;296:2319\u201328.","journal-title":"Jama"},{"key":"940_CR46","doi-asserted-by":"publisher","unstructured":"Wilt TJ, Ishani A. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 1998. \nhttps:\/\/doi.org\/10.1002\/14651858.cd001044\n\n.","DOI":"10.1002\/14651858.cd001044"},{"key":"940_CR47","doi-asserted-by":"publisher","unstructured":"Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2011. \nhttps:\/\/doi.org\/10.1002\/14651858.cd001042.pub2\n\n.","DOI":"10.1002\/14651858.cd001042.pub2"},{"key":"940_CR48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<467::AID-NAU2>3.0.CO;2-B","volume":"17","author":"JP Weiss","year":"1998","unstructured":"Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: etiology and classification. Neurourol Urodyn. 1998;17:467\u201372.","journal-title":"Neurourol Urodyn"},{"key":"940_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1464-410X.2009.08353.x","volume":"104","author":"CP Vaughan","year":"2009","unstructured":"Vaughan CP, Endeshaw Y, Nagamia Z, Ouslander JG, Johnson TM. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int. 2009;104:69\u201374.","journal-title":"BJU Int"},{"key":"940_CR50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1464-410X.2012.11736.x","volume":"112","author":"TM Johnson","year":"2013","unstructured":"Johnson TM, Markland AD, Goode PS, Vaughan CP, Colli JL, Ouslander JG, et al. Efficacy of adding behavioural treatment or antimuscarinic drug therapy to \u03b1-blocker therapy in men with nocturia. BJU Int. 2013;112:100\u20138.","journal-title":"BJU Int"},{"key":"940_CR51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/iju.12387","volume":"21","author":"M Tani","year":"2014","unstructured":"Tani M, Hirayama A, Torimoto K, Matsushita C, Yamada A, Fujimoto K. Guidance on water intake effectively improves urinary frequency in patients with nocturia. Int J Urol. 2014;21:595\u2013600.","journal-title":"Int J Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-019-0940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-019-0940-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-019-0940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T01:15:46Z","timestamp":1604798146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-019-0940-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1007\/s11934-019-0940-2","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"9 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Danielle J. Gordon, Curran Emeruwa, and Jeffrey P. Weiss each declares no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"75"}}